EUVIMEDEUVIMED entdecken
Open Access

Camptothecin improves sorafenib sensitivity by inhibiting Nrf2‑ARE pathway in hepatocellular carcinoma

Liwei Sun, Hankang Wang, Qian Liu, Fanguang Meng, Jinliang Zhang, Xiaodong Li, Shulin Chang, Guijie Li, Feng Chen

Oncology Reports · 03.02.2023 · 49 (3)

DOI: 10.3892/or.2023.8492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, online erschienen am 03.02.2023. Verfasst von Liwei Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Med…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAnimalsMiceRabbitsSorafenibNF-E2-Related Factor 2NADCamptothecinQuinonesOxidoreductasesDrug Resistance, NeoplasmCell Line, Tumor

Stichwörter der Autor:innen

Nrf2camptothecinchemoresistancehepatocellular carcinomasorafenib

Substanzen

SorafenibNF-E2-Related Factor 2NADCamptothecinQuinonesOxidoreductases

Autor:innen und Institutionen

  • Department of Radiology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Abdominal Medicine Imaging, Jinan,…
  • Department of Radiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, P.R. China.

Zitieren

APA

Sun, L., Wang, H., Liu, Q., Meng, F., Zhang, J., Li, X., Chang, S., Li, G., & Chen, F. (2023). Camptothecin improves sorafenib sensitivity by inhibiting Nrf2‑ARE pathway in hepatocellular carcinoma. Oncology Reports, 49(3). https://doi.org/10.3892/or.2023.8492

Vancouver

Sun L, Wang H, Liu Q, Meng F, Zhang J, Li X, et al. Camptothecin improves sorafenib sensitivity by inhibiting Nrf2‑ARE pathway in hepatocellular carcinoma. Oncology Reports. 2023;49(3). doi:10.3892/or.2023.8492

BibTeX
@article{Sun2023,
  author = {Sun, Liwei and Wang, Hankang and Liu, Qian and Meng, Fanguang and Zhang, Jinliang and Li, Xiaodong and Chang, Shulin and Li, Guijie and Chen, Feng},
  title = {Camptothecin improves sorafenib sensitivity by inhibiting Nrf2‑ARE pathway in hepatocellular carcinoma},
  journal = {Oncology Reports},
  year = {2023},
  volume = {49},
  number = {3},
  doi = {10.3892/or.2023.8492}
}
Kostenlos starten →